Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS)
<p>Abstract</p> <p>Background</p> <p><it>Multiple sclerosis</it> (MS) is a chronic inflammatory disorder of the central nervous system (CNS). It involves damage to the myelin sheath surrounding axons and to the axons themselves. MS most often presents with a...
Main Authors: | Jia Yan, Wu Tianxia, Jelinek Christine A, Bielekova Bibiana, Chang Linda, Newsome Scott, Gnanapavan Sharmilee, Giovannoni Gavin, Chen Dawn, Calabresi Peter A, Nath Avindra, Cotter Robert J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Clinical Proteomics |
Online Access: | http://www.clinicalproteomicsjournal.com/content/9/1/9 |
Similar Items
-
Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
by: Ruturaj Masvekar, et al.
Published: (2021-03-01) -
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
by: Mark S. Freedman, et al.
Published: (2024-03-01) -
Biomarkers in MS – the current state of play
by: Francesca Ammoscato, et al.
Published: (2019-05-01) -
The Evolution of Neurofilament Light Chain in Multiple Sclerosis
by: Carolina Ferreira-Atuesta, et al.
Published: (2021-04-01) -
Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.
by: Bibiana Bielekova, et al.
Published: (2012-01-01)